Putnam announces a new Partner promotion, Mariah Hanley

Putnam, a leading scientific and strategic consulting partner, is proud to announce that Mariah Hanley has been promoted to Partner. The firm extends its warmest congratulations to Mariah on this well-deserved achievement.

Mariah joined Putnam in 2017 after earning her PhD in Chemistry and Chemical Biology from Harvard University. Since then, she has become a trusted advisor to clients across the biopharmaceutical industry, known for her ability to translate complex findings from both primary and secondary research into clear, strategic guidance. Her work consistently delivers actionable insights grounded in rigorous analysis, empowering clients to make high-impact decisions at critical inflection points in asset and portfolio development.

Mariah brings deep expertise across a range of therapeutic areas, including neurology, rare diseases, oncology, and vaccines. She has led engagements focused on early-stage portfolio strategy, asset prioritization, pivotal trial design, and global market access, with a nuanced understanding of both inpatient and outpatient dynamics. Her thoughtful, data-driven approach has helped clients unlock the full potential of their innovations, from discovery through commercialization.

Throughout her time at Putnam, Mariah has been a valued mentor and collaborator, recognized for her intellectual curiosity, strategic mindset, and commitment to excellence. Reflecting on her promotion,
she adds “I’m incredibly grateful to reach this milestone and for the people who’ve supported me along the way. What excites me most about this next chapter is the opportunity to help shape the future of our firm, through both mentoring and developing the next generation of Putnam leaders and deepening our client impact.”

Please join the firm in congratulating Mariah.

About Putnam

Putnam is a leading scientific and strategic consulting partner that helps the global life science community make confident decisions, build value, and bring life-changing innovations to clinicians and patients. For over 30 years, our rigorous, bespoke approach and globally diverse team have maximized the human impact and commercial success of client innovations.